Evaluating the Effectiveness of Insulin Plus Oral Medications Versus Oral Anti‐Diabetes Therapy Alone in Patients With Newly Diagnosed Type 2 Diabetes With Very High <scp>hbA1c</scp> and Acute Coronary Syndrome
An anti-DM regimen consisting of multiple oral agents is a safe and effective alternative to insulin plus OAD and can lead to a comparable reduction in hbA1c at 1-year in patients who are not willing to use insulin early after diagnosis of T2DM.
Authors
- Fateen Ata (ORCID: https://orcid.org/0000-0001-7121-8574)
- Amin Jayyousi (ORCID: https://orcid.org/0000-0003-3174-3037)
- Afia Aziz (ORCID: https://orcid.org/0000-0001-8449-9184)
- Haval Surchi (ORCID: https://orcid.org/0009-0008-2786-9650)
- Ahmed Shukri
- Adeel Ahmad Khan (ORCID: https://orcid.org/0000-0003-1583-1539)
- Khaled Aboujabal (ORCID: https://orcid.org/0000-0003-1448-2381)
- Mohammed Bashir (ORCID: https://orcid.org/0000-0003-3096-2641)
- Yazan Almohtasib
- Aya Janan Qassim
Institutions
- Texas Tech University (US)
- Cleveland Clinic (US)
- Cleveland Clinic Akron General (US)
- Hamad Medical Corporation (QA)
- University of Missouri–Kansas City (US)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1002/edm2.70069
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hamad Medical Corporation
- Qatar National Library